Skip to main content
Roger De Filippo, MD, Urology, Los Angeles, CA, Torrance Memorial Medical Center

RogerEdwardDe FilippoMDFAAP, FACS

Urology • Los Angeles, CA

Pediatric Urology

Division of Pediatric Urology Children's Hospital Los Angeles

Join to view full profile

Dr. De Filippo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. De Filippo's full profile

Already have an account?

Summary

  • Chief of the Division of Urology, Children's Hospital Los Angeles
    Co-Director, GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics in Urology
    Associate Professor of Pediatric Urology, Keck School of Medicine, USC
    Co-surgical director, CAH Comprehensive Care Clinic

    Dr. De Filippo was named chief of the Division of Urology in 2014, having served interim chief since 2012, overseeing and maintaining the Division’s robust clinical and research programs. Among the many advances made during his tenure, Urology became one of the first surgical divisions at Children’s Hospital Los Angeles to implement electronic medical record-keeping in the outpatient clinic as well as in its extensive satellite network, which includes 15 offices across the Southern California region.

    Currently Dr. De Filippo is researching: The development of working renal units from stem cell sources in the laboratory for eventual transplantation in animal recipients as a viable donor kidney source, the use of amniotic fluid stem cells for cell therapeutic modes of therapy in acute and chronic renal failure, FDA-approved phase II clinical trial for tissue engineering of the bladder, isolation of progenitor cells for tissue engineering and cell therapy from amniotic fluid, multipotent stem cells and progenitor cells from amniotic fluid for the treatment of alport disease, the use of multipotent stem cells from amniotic fluid for fetal therapy for alport disease as a model for fetal therapies in genetic diseases of the kidney, the use of multipotent and progenitor stem cells from amniotic fluid for diabetes and diabetic nephropathy.

    • GOFARR LAB

    Stories like Gabriel's inspire us everyday to find new and novel therapies in our GOFARR lab.

Education & Training

  • Children’s Hospital Boston, Harvard Medical Schoo
    Children’s Hospital Boston, Harvard Medical Schoo1999 - 2003
  • LA County Medical Center/USC
    LA County Medical Center/USC1994 - 1999
  • LAC+USC Medical Center
    LAC+USC Medical CenterInternship, Rotating Intern General Surgery, 1993 - 1994
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 1993, MD, Dean’s Scholar Graduate
  • University of Southern California
    University of Southern CaliforniaBS, Biological Sciences, Magna Cum Laude, 1984 - 1988
  • Loyola High School
    Loyola High SchoolHS, 1980 - 1984
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Urology

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - 2025
  • MA State Medical License
    MA State Medical License 2000 - 2005
  • American Board of Urology Urology
  • American Board of Urology Pediatric Urology

Awards, Honors, & Recognition

  • Southern Califronia Super Doctors 2012
  • Top Doctors Pasadena Magazine, 2009, 2011
  • Southern California Super Doctors 2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Laparoendoscopic Single-site Nephrectomy in Pediatric Patients: Initial Clinical Series of Infants to Adolescents.  
    Koh CJ, De Filippo RE, Chang AY, Hardy BE, Berger A, Eisenberg M, Patil M, Aron M, Gill IS, Desai MM, Urology 76(6):1457-61
  • Protective Effect of Human Amniotic Fluid Stem Cells in Acute Tubular Necrosis.  
    Perin L, Giuliani S, Sedrakyan S, Da Sacco S, Carraro G, Liron S, Lemley KV, Rosol M, Wu S, Atala A, Warburton D, De Filippo RE, PluS One Science 5(2):e9357
  • The systemic characterization of human amniotic fluid: a potential new source of organ specific precursor cells for future regenerative medicine applications.  
    Da Sacco S, Sedrakyan S, Boldrin F, Parnigotto PP, Habibian R, Warburton D, De Filippo RE* , Perin L, J.Urology 183(3): 1193-1200
  • Join now to see all

Books/Book Chapters

  • Glenn’s Urologic Surgery. 
    Dorin RP; De Filippo REEdition 7,
  • Hinman’s Atlas of Pediatric Urologic Surgery. 
    Page 1117 - 1118Dorin RP; De Filippo REEdition 2,
  • Pediatric Urology: Surgical Complications and Management. 
    Page 2276 - 2277Dorin RP; De Filippo RE
  • Join now to see all

Abstracts/Posters

  • Single Injection of Stem Cells Derived from Amniotic Fluid Slows Down the Progression of Kidney Failure in a Mouse Model of Alport Syndrome.
    Laura Perin, Sargis Sedrakyan, Stefano Da Sacco, Astgik Petrosyan, Liron Shiri, Kevin V. Lemley, Roger De Filippo, Podium, American Society of Nephrology National Meeting, Philadelphia
  • Amniotic Fluid Stem Cells and Chronic Kidney Disease.
    Sargis Sedrakyan, Laura Perin, Stefano DaSacco, Liron Shiri, Kevin Lemley, Roger De Filippo, American Urological Association National Meeting, Washington DC
  • Protective Effect of Human Amniotic Fluid Stem Cells In Acute Tubular Necrosis.
    Laura Perin, Sargis Sedrakyan, Stefano Da Sacco, Shiri Liron, Kevin Lemley, David Warburton, and Roger E. De Filippo, American Academy of Pediatrics MA 2011, Boston
  • Join now to see all

Grant Support

  • Renal Tissue Derived From Amniotic Fluid Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2010

Professional Memberships

Other Languages

  • Italian

Hospital Affiliations

Dr. Roger De Filippo, Dr. Roger De Filippo, MD, Dr. R De Filippo, Dr. Roger Edward De Filippo